Metropolis Healthcare acquires Ambika Pathology in Kolhapur

19 Sep 2025 Evaluate

Metropolis Healthcare has acquired Dr. R.S. Patil’s Ambika Pathology Laboratory (Ambika Pathology) in Kolhapur. This marks a key milestone in Metropolis’ ‘String of Pearls’ strategy, which focuses on building strong regional clusters and expanding access to advanced diagnostics across India.

Established in 1995, Ambika Pathology Laboratory has built a strong reputation for quality, accuracy, and patient-centric care. The facility operates a central laboratory supported by 12 patient touchpoints and offers a comprehensive portfolio of tests. With nearly 75% of its revenue derived from B2C walk-in patients, Ambika has earned the trust of both patients and clinicians across Kolhapur and neighbouring towns. Its strong local connect makes it a strategic addition to Metropolis’ Western Maharashtra cluster, where the company already operates 19 laboratories across Pune, Kolhapur, Sangli, Satara, Solapur, Nashik, and Ahmednagar, supported by more than 200 patient service centres and a growing franchise network.

Metropolis Healthcare is engaged in the business of providing pathology and related healthcare services.

Metropolis Health. Share Price

1923.30 -6.10 (-0.32%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Apollo Hospital Ent. 7189.25
Max Healthcare Inst 1097.95
Narayana Hrudayalay 1916.45
Aster DM Healthcare 635.10
Global Health 1163.75
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×